# Combined Use of a Novel Cardioplegic Formula With Myocardial Protection System (MPS)® Versus Cardioplexol ® in Isolated Coronary Artery Bypass Grafting (CABG) Using MiECC;

> **NCT03612388** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 211 (actual)

## Conditions studied

- Complication of Extracorporeal Circulation
- Complication of Coronary Artery Bypass Graft

## Interventions

- **PROCEDURE:** use of a cardioplegic formula in isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation

## Key facts

- **NCT ID:** NCT03612388
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-28
- **Primary completion:** 2018-03-31
- **Final completion:** 2019-03-13
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2019-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03612388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03612388, "Combined Use of a Novel Cardioplegic Formula With Myocardial Protection System (MPS)® Versus Cardioplexol ® in Isolated Coronary Artery Bypass Grafting (CABG) Using MiECC;". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03612388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*